Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 ReNeuron GroupMedicureAmpio PharmaceuticalsMedlab ClinicalAntibe Therapeutics
SymbolLON:RENECVE:MPHNYSEAMERICAN:AMPEASX:MDCCVE:ATE
Price Information
Current PriceGBX 238C$4.60$0.4178A$0.44C$0.32
52 Week RangeN/AN/AN/AN/AN/A
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap£75.69 millionC$70.03 million$59.07 million$91.80 millionC$77.89 million
BetaN/AN/AN/AN/AN/A
Average Volume28,7009,343841,161N/A474,126
Sales & Book Value
Annual Revenue£900,000.00C$27.93 millionN/A$6.19 millionC$9.32 million
Price / Sales84.102.51N/A14.838.36
CashflowGBX 95.10 per shareC$3.65 per shareN/AA$0.08 per shareC$0.02 per share
Price / Cash2.501.26N/A5.5821.33
Book ValueGBX 100.80 per shareC$5.15 per shareN/AA$0.09 per shareC$0.03 per share
Price / Book0.020.89N/A4.7312.31
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSGBX (42.30)C($0.02)N/AA($0.03)C($0.05)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AC$0.05
Dividend YieldN/AN/AN/AN/A15.63%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.76%N/A0.88%35.82%
Current Ratio6.96%4.59%N/A9.90%3.77%
Quick Ratio6.96%4.11%N/A8.80%2.10%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees62N/A22N/A37
Shares Outstanding31.80 million15.22 million141.38 million211.02 million243.39 million
Next Earnings DateN/A8/21/2019 (Estimated)8/13/2019 (Estimated)N/A9/4/2019 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableNot Optionable
 ReNeuron GroupMedicureAmpio PharmaceuticalsMedlab ClinicalAntibe Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel